Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

128 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Risk of early surgery for Crohn's disease: implications for early treatment strategies.
Sands BE, Arsenault JE, Rosen MJ, Alsahli M, Bailen L, Banks P, Bensen S, Bousvaros A, Cave D, Cooley JS, Cooper HL, Edwards ST, Farrell RJ, Griffin MJ, Hay DW, John A, Lidofsky S, Olans LB, Peppercorn MA, Rothstein RI, Roy MA, Saletta MJ, Shah SA, Warner AS, Wolf JL, Vecchio J, Winter HS, Zawacki JK. Sands BE, et al. Among authors: hay dw. Am J Gastroenterol. 2003 Dec;98(12):2712-8. doi: 10.1111/j.1572-0241.2003.08674.x. Am J Gastroenterol. 2003. PMID: 14687822
Chemical species of lipids in bile.
Hay DW, Carey MC. Hay DW, et al. Hepatology. 1990 Sep;12(3 Pt 2):6S-14S; discussion 14S-16S. Hepatology. 1990. PMID: 2210659 Review.
Evidence for Alpha7 Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough.
Canning BJ, Liu Q, Tao M, DeVita R, Perelman M, Hay DW, Dicpinigaitis PV, Liang J. Canning BJ, et al. Among authors: hay dw. J Pharmacol Exp Ther. 2022 Feb;380(2):94-103. doi: 10.1124/jpet.121.000641. Epub 2021 Nov 15. J Pharmacol Exp Ther. 2022. PMID: 34782407
Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.
Salmon M, Luttmann MA, Foley JJ, Buckley PT, Schmidt DB, Burman M, Webb EF, DeHaas CJ, Kotzer CJ, Barrett VJ, Slack RJ, Sarau HM, Palovich MR, Lainé DI, Hay DW, Rumsey WL. Salmon M, et al. Among authors: hay dw. J Pharmacol Exp Ther. 2013 May;345(2):260-70. doi: 10.1124/jpet.112.202051. Epub 2013 Feb 22. J Pharmacol Exp Ther. 2013. PMID: 23435542
In vitro and in vivo pharmacological profile of PL-3994, a novel cyclic peptide (Hept-cyclo(Cys-His-Phe-d-Ala-Gly-Arg-d-Nle-Asp-Arg-Ile-Ser-Cys)-Tyr-[Arg mimetic]-NH(2)) natriuretic peptide receptor-A agonist that is resistant to neutral endopeptidase and acts as a bronchodilator.
Edelson JD, Makhlina M, Silvester KR, Vengurlekar SS, Chen X, Zhang J, Koziol-White CJ, Cooper PR, Hallam TJ, Hay DW, Panettieri RA Jr. Edelson JD, et al. Among authors: hay dw. Pulm Pharmacol Ther. 2013 Apr;26(2):229-38. doi: 10.1016/j.pupt.2012.11.001. Epub 2012 Nov 12. Pulm Pharmacol Ther. 2013. PMID: 23154072 Free PMC article.
128 results